The First of Its Kind in the World: The Recombinant Multivalent COVID-19 Protein Vaccine against XBB Variants by WestVac Biopharma/West China Medical Center, Sichuan University has been Approved for Clinical Trials by The National Medical Products Administration of China

On May 17, 2023, Recombinant bivalent COVID-19 protein vaccine (Sf9 cells) and recombinant trivalent COVID-19 trimeric protein vaccine (Sf9 cells) developed by WestVac Biopharma/ West China Medical…

thaipr.net

19 พ.ค. 66

SS&C Announces Latest Updates to SS&C Blue Prism Intelligent Automation Platform

SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) today announced the latest product updates to its SS&C Blue Prism Intelligent Automation Platform. The latest updates will help organizations extract value from intelligent automation programs to achieve business growth and improve the customer and employee experience. “This latest launch demonstrates our commitment to growing and accelerating our investment in […]

thaipr.net

19 พ.ค. 66

Bangladesh Lifts Fumigation Requirements on U.S. Cotton Following CCI-Sponsored U.S. Cotton Tour

A Cotton Council International (CCI)-sponsored Bangladesh Ministry of Agriculture Delegation’s U.S. visit from Oct. 30-Nov. 5, 2022, coupled with indispensable efforts by the U.S. Department of Agriculture’s (USDA) Foreign Agricultural Service (FAS) office in Dhaka, ultimately convinced the Bangladesh government to relax its nearly-five-decade-long fumigation requirement on U.S. cotton imports. This shift will remove a significant…

thaipr.net

19 พ.ค. 66
1 1,518 1,519 1,520 1,521 1,522 3,354